News Focus
News Focus
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 10737

Friday, 07/26/2013 3:07:52 PM

Friday, July 26, 2013 3:07:52 PM

Post# of 20689

Regarding MYL’s ANDA, I have no insights other than to note that MYL acquired the product from India’s Natco, where approval standards for FoB’s are relatively low.



The problem is that the FDA rarely rejects a generic but rather just lets them collect dust in a corner. It'll be a cloud over generic copax no matter what happens.